1. Home
  2. CRIS vs ENZ Comparison

CRIS vs ENZ Comparison

Compare CRIS & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • ENZ
  • Stock Information
  • Founded
  • CRIS 2000
  • ENZ 1976
  • Country
  • CRIS United States
  • ENZ United States
  • Employees
  • CRIS N/A
  • ENZ N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • ENZ Medical Specialities
  • Sector
  • CRIS Health Care
  • ENZ Health Care
  • Exchange
  • CRIS Nasdaq
  • ENZ Nasdaq
  • Market Cap
  • CRIS 32.8M
  • ENZ 34.2M
  • IPO Year
  • CRIS 2000
  • ENZ N/A
  • Fundamental
  • Price
  • CRIS $3.26
  • ENZ $0.56
  • Analyst Decision
  • CRIS Strong Buy
  • ENZ
  • Analyst Count
  • CRIS 3
  • ENZ 0
  • Target Price
  • CRIS $23.00
  • ENZ N/A
  • AVG Volume (30 Days)
  • CRIS 38.9K
  • ENZ 118.2K
  • Earning Date
  • CRIS 02-14-2025
  • ENZ 03-12-2025
  • Dividend Yield
  • CRIS N/A
  • ENZ N/A
  • EPS Growth
  • CRIS N/A
  • ENZ N/A
  • EPS
  • CRIS N/A
  • ENZ N/A
  • Revenue
  • CRIS $10,259,000.00
  • ENZ $30,314,000.00
  • Revenue This Year
  • CRIS N/A
  • ENZ N/A
  • Revenue Next Year
  • CRIS N/A
  • ENZ N/A
  • P/E Ratio
  • CRIS N/A
  • ENZ N/A
  • Revenue Growth
  • CRIS 0.44
  • ENZ N/A
  • 52 Week Low
  • CRIS $2.86
  • ENZ $0.56
  • 52 Week High
  • CRIS $17.49
  • ENZ $1.40
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.34
  • ENZ 28.08
  • Support Level
  • CRIS $3.05
  • ENZ $0.56
  • Resistance Level
  • CRIS $3.55
  • ENZ $0.69
  • Average True Range (ATR)
  • CRIS 0.24
  • ENZ 0.03
  • MACD
  • CRIS 0.03
  • ENZ 0.00
  • Stochastic Oscillator
  • CRIS 47.53
  • ENZ 11.54

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Share on Social Networks: